At the request of the patient, our Specialists are available to assist with each of the following steps in the insurance approval process for prescribed Celgene medications*:
* Celgene cannot provide insurance advice or make insurance decisions.
† Celgene provides a facilitation service and will not provide any medical input into a prior authorization or an appeal.
REVLIMID® (lenalidomide), POMALYST® (pomalidomide), and THALOMID® (thalidomide) are only available through restricted distribution programs.
Please see full Prescribing Information, including Boxed WARNINGS, for REVLIMID®, POMALYST®, THALOMID®, IDHIFA® (enasidenib), and ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Please see full Prescribing Information for VIDAZA® (azacitidine for injection).
Your Specialist is assigned based on the zip code of your office. To meet your Specialist, enter your zip code below.
This website is intended for
US healthcare professionals only
The ICD-10-CM Codes provided here are for diagnoses reasonably related to an indication or indications within the product’s approved label and are provided for your reference only. Other codes may be appropriate. Celgene makes no representation that any code is appropriate for a particular patient. Healthcare Professionals must use their independent judgment in selecting Code(s) to accurately reflect the diagnosis of the specific patient.